Related references
Note: Only part of the references are listed.Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
Jun Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
CDK1 serves as a potential prognostic biomarker and target for lung cancer
Mingyao Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma
Anke Maes et al.
BLOOD CANCER JOURNAL (2019)
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
Naris Nilubol et al.
Oncotarget (2018)
STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro
Anna Aronova et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
The molecular mechanisms of chemoresistance in cancers
Hua-Chuan Zheng
ONCOTARGET (2017)
Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
Daniel Bulzico et al.
ENDOCRINE (2017)
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Siyuan Zheng et al.
CANCER CELL (2016)
A High-Throughput Screen Identifies 2,9-Diazaspiro[5.5]Undecanes as Inducers of the Endoplasmic Reticulum Stress Response with Cytotoxic Activity in 3D Glioma Cell Models
Natalia J. Martinez et al.
PLOS ONE (2016)
Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
Felix Beuschlein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
The history and future of targeting cyclin-dependent kinases in cancer therapy
Uzma Asghar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
W. G. Jiang et al.
SEMINARS IN CANCER BIOLOGY (2015)
Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition
Aude Salomon et al.
ONCOTARGET (2015)
3D Cell Culture Systems: Advantages and Applications
Maddaly Ravi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers
Alison M. Karst et al.
CANCER RESEARCH (2014)
Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma
Elisabetta Kuhn et al.
MODERN PATHOLOGY (2014)
Integrated genomic characterization of adrenocortical carcinoma
Guillaume Assie et al.
NATURE GENETICS (2014)
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A. Mathews Griner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
Yubao Wang et al.
ELIFE (2014)
Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993
Thomas M. A. Kerkhofs et al.
EUROPEAN JOURNAL OF CANCER (2013)
Update in Adrenocortical Carcinoma
Martin Fassnacht et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs
D. Cirstea et al.
LEUKEMIA (2013)
Silencing Mutated β-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R
Sebastien Gaujoux et al.
PLOS ONE (2013)
MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
Kaushal Joshi et al.
STEM CELLS (2013)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients
Maurizio Scaltriti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Epithelial-mesenchymal Transition and Cell Invasion
Hwajin Son et al.
TOXICOLOGICAL RESEARCH (2010)
Cyclin B2 suppresses mitotic failure and DNA re-replication in human somatic cells knocked down for both cyclins B1 and B2
S. Bellanger et al.
ONCOGENE (2007)
Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase
Kengo Okamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress?
E Kebebew et al.
WORLD JOURNAL OF SURGERY (2006)
The role of stathmin in the regulation of the cell cycle
CI Rubin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
The effect of stathmin phosphorylation on microtubule assembly depends on tubulin critical concentration
P Amayed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)